XPO1 regulates erythroid differentiation and is a new target for the treatment of β-thalassemia.
Guillem F, Dussiot M, Colin E, Suriyun T, Arlet JB, Goudin N, Marcion G, Seigneuric R, Causse S, Gonin P, Gastou M, Deloger M, Rossignol J, Lamarque M, Choucair ZB, Gautier EF, Ducamp S, Vandekerckhove J, Moura IC, Maciel TT, Garrido C, An X, Mayeux P, Mohandas N, Courtois G, Hermine O.
Guillem F, et al. Among authors: vandekerckhove j.
Haematologica. 2020 Sep 1;105(9):2240-2249. doi: 10.3324/haematol.2018.210054.
Haematologica. 2020.
PMID: 33054049
Free PMC article.